TEVA PHARMACEUTICAL INDUSTRIES revenue for the last year amounted to 344.93 B MXN, the most of which — 344.93 B MXN — came from its highest performing source at the moment, Generics, Innovative Medicines and Biopharmaceuticals, the year earlier bringing 269.15 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought TEVA PHARMACEUTICAL INDUSTRIES 167.50 B MXN, and the year before that — 137.99 B MXN.